Related Experiment Video

Updated: Jun 22, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Targeted genetic and viral therapy for advanced head and neck cancers

Pin-I Huang1, Ju-Fang Chang, David H Kirn

  • 1Cancer Center, Taipei Veterans General Hospital, School of Medicine, National Yang-Ming University, Taipei, Taiwan.

Drug Discovery Today
|June 11, 2009
PubMed

Insights

Novel genetic and oncolytic virotherapies show promise for advanced head and neck cancers. This review summarizes clinical data, highlighting challenges and future directions for these innovative cancer treatments.

Area of Science:

  • Oncology
  • Gene Therapy
  • Virology

Background:

  • Advanced head and neck cancers often require novel therapeutic strategies.
  • Current treatments face limitations, necessitating exploration of new modalities.
  • Genetic and virotherapies offer promising avenues for cancer treatment.

Purpose of the Study:

  • To review the clinical data of genetic and oncolytic virotherapies for head and neck cancers.
  • To discuss the potential and challenges associated with these novel therapeutic approaches.
  • To explore future directions in the treatment of advanced head and neck cancers.

Main Methods:

  • Review of preclinical and clinical studies on genetic and oncolytic virotherapies.
  • Analysis of available clinical data for efficacy and safety.
  • Discussion of regulatory approvals and ongoing research.

Main Results:

  • Genetic therapy targets tumor suppressor or proapoptotic genes.
  • Oncolytic virotherapeutics utilize cancer-specific viral replication for tumor destruction.
  • Armed oncolytic viruses can express therapeutic transgenes.
  • Two products (Gendicine and H101) have received governmental approval.

Conclusions:

  • Genetic and oncolytic virotherapies demonstrate significant potential for advanced head and neck cancers.
  • Further research and clinical trials are needed to overcome existing challenges.
  • These novel therapies represent a promising frontier in head and neck cancer treatment.

More Related Videos

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma07:59

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Published on: April 3, 2026

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...